George Kukolj
R&d
Laval, QC, Canada
Laval, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse model.
Journal: Frontiers in immunology
Published: January 17, 2025
AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level.
Journal: Frontiers in immunology
Published: April 22, 2024
Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation.
Journal: Journal of virology
Published: February 05, 2024
Identification of a potent and specific retinoic acid-inducible gene 1 pathway activator as a Hepatitis B Virus antiviral through a novel cell-based reporter assay.
Journal: Journal of virological methods
Published: August 07, 2023
Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
Journal: Journal of virology
Published: October 09, 2018
An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
Journal: AIDS (London, England)
Published: November 08, 2017
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.
Journal: Clinical and experimental gastroenterology
Published: December 07, 2016
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Journal: Journal of virology
Published: October 29, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.
Journal: Antimicrobial agents and chemotherapy
Published: July 07, 2016
Baseline Polymorphisms and Emergence of Drug Resistance in the NS3/4A Protease of Hepatitis C Virus Genotype 1 following Treatment with Faldaprevir and Pegylated Interferon Alpha 2a/Ribavirin in Phase 2 and Phase 3 Studies.
Journal: Antimicrobial agents and chemotherapy
Published: April 21, 2015
Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection.
Journal: Journal of medicinal chemistry
Published: November 14, 2014
Last Updated: 09/26/2026